Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Oct 2022 for ChemoCentryx, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Thomas A. Edwards: trading record in brief
Thomas A. Edwards (board member) discloses dealings in ChemoCentryx, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 20 May 2021 to 20 October 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 24 October 2022: a transaction, in ChemoCentryx, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas A. Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
143,306 sharesCommon StockSEC:0000899243-22-034086:0
15,723 shares0Common StockSEC:0001209191-22-033031:0
7,726 shares0Common StockSEC:0001209191-21-035527:0
3 of 3 declarations
